USPTO serial 76393131
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Redwood City, CA
Redwood City, CA
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
STEPHANIE K. WADE
STEPHANIE K WADE DICKSTEIN SHAPIRO MORIN & OSHINSKY LLP2101 L STREEC, N WWASHINGTON, DC 20037-1526UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemicals and biochemicals, namely, genes and proteins, prokaryotic and eukaryotic strains, and chemical and biochemical catalysts, namely all used for scientific, research and commercial applications pertaining to chemistry, biochemistry, biology, agriculture, nutrition, chemicals, pharmaceuticals, diagnostics, medicine, bioremediation, decontamination, detoxification, and cleaning | ACTIVE | — |
| 005 | pharmaceutical preparations for the prevention and treatment of cardiovascular, dental and periodontal, dermatologic, endocrine and metabolic, gastrointestinal, genetic, hematologic, hepatic, immunologic, lymphatic, osteologic, neurologic, ophthalmic, psychiatric, respiratory tract, and renal and urinary tract diseases and disorders; pharmaceutical preparations, namely, analgesics, antibiotics, anti-cancer preparations; anti-infectives, anti-parasitics, antivirals; insulin; hormones; medical diagnostic preparations and reagents; herbicides, pesticides, biopesticides, miticides, and weedkillers, all for agricultural and domestic use; vaccines; adjuvants for use with vaccines | ACTIVE | — |
| 040 | directed evolution services, namely the recombination of genes for the benefit of others to produce novel genes and proteins for use in science, research, chemistry, agriculture, pharmaceuticals, diagnostics, vaccines, medicine and industry; manufacture of chemicals for others | ACTIVE | — |
| 042 | chemical research services; scientific research services; research, product development, and process development services for others in the fields of genetics, gene therapy, vaccines, transgenic plants, chemistry, pharmaceuticals, diagnostics, herbicides, pesticides, biopesticides, cytotoxic agents, bacteriology, biocatalysis, metabolic pathways and biochemical pathways | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 4, 2004 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 15, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 22, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 2, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 21, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 2, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 2, 2003 | PAPER RECEIVED | — | |
| Oct 11, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 7, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 2, 2002 | DOCK | ASSIGNED TO EXAMINER | — |